166 related articles for article (PubMed ID: 6794354)
1. Rocket immunoelectrophoresis of C4 and C4d. A simple sensitive method for detecting complement activation in plasma.
Nitsche JF; Tucker ES; Sugimoto S; Vaughan JH; Curd JG
Am J Clin Pathol; 1981 Nov; 76(5):679-84. PubMed ID: 6794354
[TBL] [Abstract][Full Text] [Related]
2. Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4.
Milgrom H; Curd JG; Kaplan RA; Müller-Eberhard HJ; Vaughan JH
J Immunol; 1980 Jun; 124(6):2780-5. PubMed ID: 7373050
[TBL] [Abstract][Full Text] [Related]
3. Preparation of antibodies against the fourth complement component (C4) and development of a direct electroimmunoassay for quantification of C4d.
Folkersen J; Teisner B; Petersen NE; Sim RB; Jessen E
J Clin Lab Immunol; 1985 Mar; 16(3):163-7. PubMed ID: 4032454
[TBL] [Abstract][Full Text] [Related]
4. Classical and alternative complement pathway activation in paracoccidioidomycosis.
de Messias IT; Mohren D
J Investig Allergol Clin Immunol; 1994; 4(2):91-5. PubMed ID: 7921333
[TBL] [Abstract][Full Text] [Related]
5. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
[TBL] [Abstract][Full Text] [Related]
7. Assessment of complement activation in clinical samples. Comparison of immunochemical and functional measurements of complement components with quantitation of activation fragments.
Maillet F; Frémeaux-Bacchi V; Uhring-Lambert B; Kazatchkine MD
J Immunol Methods; 1992 Dec; 156(2):171-8. PubMed ID: 1474254
[TBL] [Abstract][Full Text] [Related]
8. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
Buyon JP; Tamerius J; Ordorica S; Young B; Abramson SB
Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
[TBL] [Abstract][Full Text] [Related]
9. The absence of detectable complement activation in aspirin-sensitive asthmatic patients during aspirin challenge.
Pleskow WW; Chenoweth DE; Simon RA; Stevenson DD; Curd JG
J Allergy Clin Immunol; 1983 Nov; 72(5 Pt 1):462-8. PubMed ID: 6630797
[TBL] [Abstract][Full Text] [Related]
10. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
Senaldi G; Makinde VA; Vergani D; Isenberg DA
Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
[TBL] [Abstract][Full Text] [Related]
11. The value of rocket immunoelectrophoresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency.
Zuraw BL; Sugimoto S; Curd JG
J Allergy Clin Immunol; 1986 Dec; 78(6):1115-20. PubMed ID: 3782676
[TBL] [Abstract][Full Text] [Related]
12. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
Zwirner J; Dobos G; Götze O
J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
[TBL] [Abstract][Full Text] [Related]
13. Complement activation by cellulosic dialysis membranes.
Innes A; Farrell AM; Burden RP; Morgan AG; Powell RJ
J Clin Pathol; 1994 Feb; 47(2):155-8. PubMed ID: 8132830
[TBL] [Abstract][Full Text] [Related]
14. Classical pathway of complement activation in normal and diseased human glomeruli.
Zwirner J; Felber E; Herzog V; Riethmüller G; Feucht HE
Kidney Int; 1989 Dec; 36(6):1069-77. PubMed ID: 2689750
[TBL] [Abstract][Full Text] [Related]
15. Screening test for complement activation by counterimmunoelectrophoresis.
Arroyave CM; Taylor DG; Gallup P; Nakamura RM
Am J Clin Pathol; 1978 Apr; 69(4):440-5. PubMed ID: 417620
[TBL] [Abstract][Full Text] [Related]
16. Classical pathway of complement activation in mammalian kidneys.
Zwirner J; Felber E; Burger R; Bitter-Suermann D; Riethmüller G; Feucht HE
Immunology; 1993 Oct; 80(2):162-7. PubMed ID: 8262545
[TBL] [Abstract][Full Text] [Related]
17. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
J Infect Dis; 1990 Dec; 162(6):1227-32. PubMed ID: 1977807
[TBL] [Abstract][Full Text] [Related]
18. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway.
Wolbink GJ; Bollen J; Baars JW; ten Berge RJ; Swaak AJ; Paardekooper J; Hack CE
J Immunol Methods; 1993 Jul; 163(1):67-76. PubMed ID: 7687639
[TBL] [Abstract][Full Text] [Related]
19. [The in vitro inhibitory effect of sodium selenite on complement activation].
Li B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):195-8. PubMed ID: 1652384
[TBL] [Abstract][Full Text] [Related]
20. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
Petersen NE; Elmgreen J; Teisner B; Svehag SE
Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
